Cargando…

Bisphosphonate Therapy in the Management of Symptomatic Melorheostosis of Tibia

INTRODUCTION: Melorheostosis is a rare sclerosing bone disease characterized by linear hyperostotic bone dysplasia with its radiological appearance as melting candle wax dripping by its side. It usually affects long bones, especially the lower limb. The exact cause of the disease has not been clearl...

Descripción completa

Detalles Bibliográficos
Autores principales: Sathish, Muthu, Girinivasan, Chellamuthu, Srinivasacholan, Chandrasekaran, Gowtham, Palani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Indian Orthopaedic Research Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930359/
https://www.ncbi.nlm.nih.gov/pubmed/35415166
http://dx.doi.org/10.13107/jocr.2021.v11.i09.2436
_version_ 1784671047902035968
author Sathish, Muthu
Girinivasan, Chellamuthu
Srinivasacholan, Chandrasekaran
Gowtham, Palani
author_facet Sathish, Muthu
Girinivasan, Chellamuthu
Srinivasacholan, Chandrasekaran
Gowtham, Palani
author_sort Sathish, Muthu
collection PubMed
description INTRODUCTION: Melorheostosis is a rare sclerosing bone disease characterized by linear hyperostotic bone dysplasia with its radiological appearance as melting candle wax dripping by its side. It usually affects long bones, especially the lower limb. The exact cause of the disease has not been clearly explained though many theories are available. It is insidious in onset and symptoms being pain, deformity, and joint stiffness. Although there is no definitive treatment, the administration of bisphosphonates dramatically reduces pain and improves the patient clinically. CASE REPORT: We described a case of a 28-year-old female who presented with a history of pain and swelling in her left leg for the past 2 years. The onset of complaints was insidious. On physical examination, there was tender swelling over the shaft of the tibia with irregular borders. Knee and ankle range of movements were normal. Radiographs showed hyperostosis of the proximal two-thirds of the tibia of the left leg with a flowing candle wax appearance. The patient was treated with a single dose of intravenous zolendronic acid and physical therapy. The patient had dramatic alleviation of pain without the need for any further treatment till 1 year follow-up. CONCLUSION: Although there is no specific treatment available for this disease, the intravenous infusion of zolendronic acid has dramatically improved the patient clinically.
format Online
Article
Text
id pubmed-8930359
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Indian Orthopaedic Research Group
record_format MEDLINE/PubMed
spelling pubmed-89303592022-04-11 Bisphosphonate Therapy in the Management of Symptomatic Melorheostosis of Tibia Sathish, Muthu Girinivasan, Chellamuthu Srinivasacholan, Chandrasekaran Gowtham, Palani J Orthop Case Rep Case Report INTRODUCTION: Melorheostosis is a rare sclerosing bone disease characterized by linear hyperostotic bone dysplasia with its radiological appearance as melting candle wax dripping by its side. It usually affects long bones, especially the lower limb. The exact cause of the disease has not been clearly explained though many theories are available. It is insidious in onset and symptoms being pain, deformity, and joint stiffness. Although there is no definitive treatment, the administration of bisphosphonates dramatically reduces pain and improves the patient clinically. CASE REPORT: We described a case of a 28-year-old female who presented with a history of pain and swelling in her left leg for the past 2 years. The onset of complaints was insidious. On physical examination, there was tender swelling over the shaft of the tibia with irregular borders. Knee and ankle range of movements were normal. Radiographs showed hyperostosis of the proximal two-thirds of the tibia of the left leg with a flowing candle wax appearance. The patient was treated with a single dose of intravenous zolendronic acid and physical therapy. The patient had dramatic alleviation of pain without the need for any further treatment till 1 year follow-up. CONCLUSION: Although there is no specific treatment available for this disease, the intravenous infusion of zolendronic acid has dramatically improved the patient clinically. Indian Orthopaedic Research Group 2021-09 2021-09 /pmc/articles/PMC8930359/ /pubmed/35415166 http://dx.doi.org/10.13107/jocr.2021.v11.i09.2436 Text en Copyright: © Indian Orthopaedic Research Group https://creativecommons.org/licenses/by-nc-sa/3.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Sathish, Muthu
Girinivasan, Chellamuthu
Srinivasacholan, Chandrasekaran
Gowtham, Palani
Bisphosphonate Therapy in the Management of Symptomatic Melorheostosis of Tibia
title Bisphosphonate Therapy in the Management of Symptomatic Melorheostosis of Tibia
title_full Bisphosphonate Therapy in the Management of Symptomatic Melorheostosis of Tibia
title_fullStr Bisphosphonate Therapy in the Management of Symptomatic Melorheostosis of Tibia
title_full_unstemmed Bisphosphonate Therapy in the Management of Symptomatic Melorheostosis of Tibia
title_short Bisphosphonate Therapy in the Management of Symptomatic Melorheostosis of Tibia
title_sort bisphosphonate therapy in the management of symptomatic melorheostosis of tibia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930359/
https://www.ncbi.nlm.nih.gov/pubmed/35415166
http://dx.doi.org/10.13107/jocr.2021.v11.i09.2436
work_keys_str_mv AT sathishmuthu bisphosphonatetherapyinthemanagementofsymptomaticmelorheostosisoftibia
AT girinivasanchellamuthu bisphosphonatetherapyinthemanagementofsymptomaticmelorheostosisoftibia
AT srinivasacholanchandrasekaran bisphosphonatetherapyinthemanagementofsymptomaticmelorheostosisoftibia
AT gowthampalani bisphosphonatetherapyinthemanagementofsymptomaticmelorheostosisoftibia